Atlas Trials

A Study to Determine Effective and Tolerable Titration Scheme for OROS-Methylphenidate in Children With Attention-deficit Hyperactivity Disorder

Clinical trial NCT00518232 · COMPLETED

Trial details

NCT number
NCT00518232
Sponsor
Johnson & Johnson Taiwan Ltd
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Attention Deficit Hyperactivity Disorder
Start date
2006-09-01
Primary completion
2007-06-01
Enrollment
520

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.